JP2024543134A5 - - Google Patents

Info

Publication number
JP2024543134A5
JP2024543134A5 JP2024531051A JP2024531051A JP2024543134A5 JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5 JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5
Authority
JP
Japan
Prior art keywords
domain
monovariate
immunoglobulin
modified immunoglobulin
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/134923 external-priority patent/WO2023093899A1/zh
Publication of JP2024543134A publication Critical patent/JP2024543134A/ja
Publication of JP2024543134A5 publication Critical patent/JP2024543134A5/ja
Pending legal-status Critical Current

Links

JP2024531051A 2021-11-29 2022-11-29 修飾されたタンパク質又はポリペプチド Pending JP2024543134A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111429892.3 2021-11-29
CN202111429892 2021-11-29
PCT/CN2022/134923 WO2023093899A1 (zh) 2021-11-29 2022-11-29 经修饰的蛋白或多肽

Publications (2)

Publication Number Publication Date
JP2024543134A JP2024543134A (ja) 2024-11-19
JP2024543134A5 true JP2024543134A5 (cg-RX-API-DMAC7.html) 2026-03-27

Family

ID=86538884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531051A Pending JP2024543134A (ja) 2021-11-29 2022-11-29 修飾されたタンパク質又はポリペプチド

Country Status (6)

Country Link
US (1) US20250026842A1 (cg-RX-API-DMAC7.html)
EP (1) EP4435002A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024543134A (cg-RX-API-DMAC7.html)
CN (1) CN118339179A (cg-RX-API-DMAC7.html)
TW (1) TW202330596A (cg-RX-API-DMAC7.html)
WO (1) WO2023093899A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024114676A1 (zh) 2022-11-29 2024-06-06 江苏恒瑞医药股份有限公司 Cldn18.2/4-1bb结合蛋白及其医药用途
CN121949445A (zh) * 2026-01-27 2026-05-01 北京工商大学 一种核桃源dpp-iv抑制肽及其制备筛选方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
US7288638B2 (en) 2003-10-10 2007-10-30 Bristol-Myers Squibb Company Fully human antibodies against human 4-1BB
EP3363813A1 (en) * 2011-06-23 2018-08-22 Ablynx NV Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
CA3141978A1 (en) * 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
MY167125A (en) * 2011-08-17 2018-08-13 Glaxo Group Ltd Modified proteins and peptides
JP6351572B2 (ja) * 2012-05-10 2018-07-04 ザイムワークス,インコーポレイテッド Fcドメインに突然変異を有する免疫グロブリン重鎖のヘテロ多量体構築物
WO2014111550A1 (en) * 2013-01-17 2014-07-24 Glaxosmithkline Intellectual Property Development Limited Modified anti-serum albumin binding proteins
LT3248986T (lt) * 2014-05-16 2022-03-25 Ablynx Nv Imunoglobulino kintami domenai
EP3247407A4 (en) 2015-01-21 2018-08-22 Inhibrx LP Non-immunogenic single domain antibodies
NO2768984T3 (cg-RX-API-DMAC7.html) * 2015-11-12 2018-06-09
CN113621065B (zh) * 2021-08-30 2023-08-01 武汉海沙百得生物技术有限公司 靶向4-1bb的全人源抗体及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2021503455A5 (cg-RX-API-DMAC7.html)
JP2021191763A5 (cg-RX-API-DMAC7.html)
JP2021073279A (ja) Igf−1r抗体および癌処置のためのアドレッシングビヒクルとしてのその使用
US20250034248A1 (en) Monoclonal antibodies against human tim-3
CA3005085C (en) IMPROVED TNF BINDERS
JP2020525032A5 (cg-RX-API-DMAC7.html)
JP2018522888A5 (cg-RX-API-DMAC7.html)
JP2019520797A5 (cg-RX-API-DMAC7.html)
JP2019533719A5 (cg-RX-API-DMAC7.html)
JP2017529067A (ja) Cd3結合ドメイン
JP2016529882A5 (cg-RX-API-DMAC7.html)
JP2019502656A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2018526981A5 (cg-RX-API-DMAC7.html)
JP2019501883A5 (cg-RX-API-DMAC7.html)
JP2023516280A5 (cg-RX-API-DMAC7.html)
JP2021520832A5 (cg-RX-API-DMAC7.html)
JP2018510636A5 (cg-RX-API-DMAC7.html)
JP2013500703A5 (cg-RX-API-DMAC7.html)
AU2015322141A1 (en) High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH
JP2021512159A5 (cg-RX-API-DMAC7.html)
JP2021511387A5 (cg-RX-API-DMAC7.html)
JP2023543493A5 (cg-RX-API-DMAC7.html)
CA3173257A1 (en) C19 c38 bispecific antibodies
JP2020502233A5 (cg-RX-API-DMAC7.html)
JP2023522212A5 (cg-RX-API-DMAC7.html)